HAL (France)open access
Metal-based epigenetic therapeutics in cancer: Mechanisms, targets, and opportunities for overcoming drug resistance
Epigenetic drugs, Histone deacetylase inhibitors, Therapeutic resistance, Metallodrugs, 0, Cancer epigenetics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1066239
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.